Rigel Pharmaceuticals (RIGL) Leases (2019 - 2025)
Historic Leases for Rigel Pharmaceuticals (RIGL) over the last 7 years, with Q3 2025 value amounting to $1.0 million.
- Rigel Pharmaceuticals' Leases rose 15925.93% to $1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year increase of 15925.93%. This contributed to the annual value of $246000.0 for FY2024, which is 7142.86% down from last year.
- As of Q3 2025, Rigel Pharmaceuticals' Leases stood at $1.0 million, which was up 15925.93% from $1.2 million recorded in Q2 2025.
- In the past 5 years, Rigel Pharmaceuticals' Leases ranged from a high of $15.9 million in Q1 2021 and a low of $246000.0 during Q4 2024
- For the 5-year period, Rigel Pharmaceuticals' Leases averaged around $4.1 million, with its median value being $1.2 million (2025).
- Its Leases has fluctuated over the past 5 years, first tumbled by 8509.03% in 2023, then surged by 15925.93% in 2025.
- Rigel Pharmaceuticals' Leases (Quarter) stood at $9.7 million in 2021, then tumbled by 80.11% to $1.9 million in 2022, then crashed by 55.39% to $861000.0 in 2023, then crashed by 71.43% to $246000.0 in 2024, then soared by 326.83% to $1.0 million in 2025.
- Its Leases stands at $1.0 million for Q3 2025, versus $1.2 million for Q2 2025 and $1.3 million for Q1 2025.